BioTuesdays

Tag - BMT

Actinium gearing up for pivotal trial in second half

By Len Zehr Actinium Pharmaceuticals (NYSE MKT:ATNM) expects to begin a Phase 3 trial in the second half this year of its Iomab-B drug candidate as a conditioning agent in elderly patients with relapsed/refractory acute...